Patents systems

The patented system (15) has stationary disks mounted inside a pressure vessel (horizontal vessel, vertical disks) which is mounted on rollers and can rotate slowly about its axis. A screw conveyor is mounted in the stationary center of rotation it conveys the cake, which is blown off the leaves when they pass above the screw, to one end of the vessel where it falls into a vertical chute. The cake discharge system involves two linear sHde valves that sHde the cake through compartments which gradually depressurize it and move it out of the vessel without any significant loss of pressure. The system rehes entirely on the cake falling freely from one compartment to another as the valves move across. This may be an unrealistic assumption, particularly with sticky cakes when combined with lots of sliding contact surfaces which are prone to abrasion and jamming, the practicality of the system is questionable. 

Best Mode. The patent appHcant must disclose the best mode of practicing the invention known to the inventor at the time the appHcation is filed. Concerns over best mode often arise when a patent appHcant seeks patent protection for an invention but, at the same time, desires to keep as a trade secret one aspect of the invention necessary to the production of a commercial product. This action denies the pubHc access to this information and undermines the poHcies of the patent system. This would effectively deprive the pubHc of information on the amount of disclosure made in exchange for the 17-yr patent grant, and hence it invaHdates the patent grant. 

Attenlion should be drawn to ihe use of tin oxide systems as heterogeneous catalysts. The oldest and mosi extensively patented systems are the mixed lin-vanadium oxide catalysis for the oxidation of aromatic compounds such as benzene, toluene, xylenes and naphthalene in the. synthesis of organic acids and acid anhydride.s. More recenily mixed lin-aniimony oxides have been applied lo the selective oxidaiion and ammoxidaiion of propylene to acrolein, acrylic acid and acrylonilrile. 

In 1790 the formal U.S. Patent system was founded. Since that time the U.S. Patent Office has undergone numerous changes that have generally improved legal protection for intellectual property owned by individual citizens. 

This chapter offers an overview of the role played by technical information in the development of innovation and the necessary incentives for its creation, and at the same time the implications for the pharmaceutical sector. To this end, we present the basis and the significance of the patent system, we offer an analysis of the impact of this system, and lasdy we present a reflection on the future of the system and its relationship with the pharmaceutical industry. 

Those inventions that are valuable for society, which include innovative pharmaceuticals, generate positive externalities, that is, the benefits falls to society at large. The sum of these benefits gives the social benefit or value of the invention. In this way, patents represent the appropriation of part of this social value. Naturally, when businesses decide to undertake a project they do so with their own benefit in mind. Some research, particularly basic research, might not be undertaken in these circumstances, and therefore governments decide to invest to fill the gap that may be left by the patent system. Basic research allows the development of multiple applications and the discovery of scientific principles. The field of genetics is a prime example of this. 

On the other hand, under the patent system, incentives to carry out research come from the expected monopoly revenue. This leads to two imperfections. First, the incentives to do research are inadequate, because the monopoly benefits are less than the social surplus generated by the innovation. Second,... 

A straightforward comparison between the two systems would show first of all the superiority of the grant system, as the welfare loss due to monopoly prices is diluted. However, the incentives to carry out research are imperfect in both systems, although in a different way. In the patent system they are always inadequate because the monopoly benefits are less than the social surplus. In the grant system, the incentives to invest are not systematically inadequate, as they are related to the reward received rather than to the real surplus. 

The theoretical conclusion they reach is that the system of grants, or optional grants, especially those related to sales information, is an alternative that represents an improvement on the patent system inasmuch as it allows incentives to be attached to innovation without the need for a monopoly power. Further research will be necessary before this method can be adopted on a practical and experimental level. 

The differences in authorization regulations for new products go some way towards explaining the greater therapeutic rivalry in Spain. However, we need to complete the picture with a review of the differences in the patent system in order to understand why generic competition is greater in the UK. 

Innovation displays the typical characteristics of a public good there is no rivalry in consumption and - in the absence of a patent system - it is difficult to exclude economic units who are unwilling to pay for the good. 

When the RP system was introduced in Germany it included patented products, although they were exempted in Januaiy 1996. In other countries such as Denmark and Sweden, the system only covers products whose patents have expired and generics. The inclusion of drags with extant patents in the RP system reduces the efficiency of the patent system and may cause dynamic... 

In my essays it was stated that the people of Europe would approach each other economically more closely after the war. In the patent field, I said, internal conditions in Europe bordered on the ridiculous. There were no fewer than thirty different patent systems in Europe I said. The Vatican had its own patent laws. The City of Gibraltar, the Island of Malta, and even the tiny Channel Islands between England and France had their own patent laws. 

An amazing paradox The lawyer who was responsible for hiding millions of dollars in assets, for obscuring the true owner of the Jasco patents in the United States, was dreaming up a uniform patent system under which the fruits of Europe s scientific labors would be open to all. 

There was only one plausible explanation. He had taken part, albeit with distaste, in the robberies in Poland. From the spoils of Austria, Czechoslovakia, and Poland, Farben had already formed its own Central Patent Agency. In fact, Farben was on its way to running the whole European patent system anyway. In these calm essays, Von Knieriem could rewrite the Farben depredations in those other countries, while looking to a future where the contracts read like a clear conscience. 

Allison, J. and Lemley, M. 2002. The growing complexity of the United States patenting system. Boston University Law Review 82(1), 77-144. 

Farnley, S., Morey-Nase, P., and Sternfeld, D. 2004. Biotechnology - a challenge to the patent system. Current... 

The patent system is an essential foundation of the biotechnology industry Through patent protection, those spending extraordinary amounts of money on research and development are able to recoup costs and earn appropriate returns for shareholders by benefiting from limited periods of exclusivity over their discoveries. The importance of this protection becomes obvious as one considers that the average research and development costs for a single new drug has traditionally been estimated at 500 million (Robbins-Roth,... 

Every country in the world has found reason to have a patent system. It is intended as an incentive system, an incentive for a major aspect of the economy that which has to do with new products and new ideas, the commercial use of new ideas, and the investment of risk capital in new products. This incentive is more important in some fields than in others. For example, in the pharmaceutical and pesticide fields, one wonders whether there would even be private research without patents. Many people think not—or not on the present scale, but then the government, HEW, and the Department of Agriculture might fill the... 

Many new businesses started with an idea and a patent. How would they have been affected by a diminished patent system Would small inventors with good ideas merely try to sell the ideas to big business in the knowledge that without patents they couldn t compete with big business What is the inventor s protection against appropriation of his idea while he is trying to sell it ... 

---